Recent Activity

Loading...

NVRO

Nevro Corp. · NYSE

Performance

+8.47%

1W

-10.24%

1M

-34.18%

3M

-32.58%

6M

-47.03%

YTD

-58.96%

1Y

Profile

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Investment Analysis Report: NVRO

Overview

NVRO is a company operating in the Health Technology sector, specifically in the Medical Specialties industry. In this report, we will conduct a comprehensive analysis of NVRO's financial statements over the past three years, focusing on the Balance Sheets, Income Statements, and Cashflow Statements. The...

See more ...

Technical Analysis of NVRO 2024-05-10

Overview:

In analyzing the technical indicators for NVRO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates